Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-24 @ 5:30 PM
NCT ID:
NCT07017868
Eligibility Criteria:
Inclusion Criteria:
* ● Aged ≥18 years.
* SLE patients fulfilling the SLE International Collaborating Clinics (SLICC) classification criteria and matched controls.
* Patients cooperative and can answer questions.
* Patients who are able and willing to give written informed consent
Exclusion Criteria:
* ● Individuals with other autoimmune diseases.
* Patients receive any hyperuricemia treatment
* Pregnancy
* Malignancy
* Diabetes.
* Hypertension.
* Heart failure.
* Hepatic diseases.
* Chronic renal failure other than lupus nephritis.
* Renal artery stenosis.
* Renal vein thrombosis.
* Intrarenal arteriovenous fistula.
* Obstructive nephropathy.
* Urinary tract obstruction that could affect RI of intra renal arteries.
* Uncooperative patients.
* Patients not able and willing to give written informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07017868
Study Brief:
Protocol Section:
NCT07017868